Edesa Biotech is trading 6.7% lower at $3.93 on October 1, 2026, with no specific announcement identified to explain the decline.
- Shares rose 18.26% to close at $4.21 on September 30, before reversing sharply.
- The company’s latest news-page releases are dated August 19, 2026; broad market indices were little changed, leaving no clear company or market catalyst.